Crohn and Bone: A quest for the mechanism of inflammation-induced osteoporosis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  2011-09-08

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn's disease.

  2011influential reference
• Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease

  2010cited by this paper
• Exploring the full spectrum of macrophage activation

  2010cited by this paper
• Bone loss in inflammatory disorders.

  2009cited by this paper
• Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells

  2008influential reference
• Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women

  2007cited by this paper
• Inflammation Is The Main Determinant of Low Bone Mineral Density in Pediatric Inflammatory Bowel Disease

  2007influential reference
• Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo

  2006cited by this paper
• Altered levels of biochemical indices of bone turnover and bone‐related vitamins in patients with Crohn's disease and ulcerative colitis

  2006cited by this paper
• Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.

  2006cited by this paper
• Increased Circulating Concentrations of Growth-Related Oncogene (GRO)-α in Patients with Inflammatory Bowel Disease

  2006cited by this paper
• The cellular basis of bone remodeling: The quantum concept reexamined in light of recent advances in the cell biology of bone

  2006cited by this paper
• The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

  2005cited by this paper
• Maintenance Infliximab Treatment Is Associated with Improved Bone Mineral Density in Crohn's Disease

  2005influential reference
• Differences in Osteocyte Density and Bone Histomorphometry Between Men and Women and Between Healthy and Osteoporotic Subjects

  2005cited by this paper
• Effect of antitumour necrosis factor‐α therapy on bone turnover in patients with active Crohn's disease: a prospective study

  2004influential reference
• A global test for groups of genes: testing association with a clinical outcome

  2004cited by this paper
• Soluble Selectins, sICAM, sVCAM, and Angiogenic Proteins in Different Activity Groups of Patients with Inflammatory Bowel Disease

  2004cited by this paper
• Inflammation and necrosis promote tumour growth

  2004cited by this paper
• Relationships between Serum IGF-1, IGFBP-2, Interleukin-1Beta and Interleukin-6 in Inflammatory Bowel Disease

  2004cited by this paper
• The Insulin-Like Growth Factor System

  2003cited by this paper
• Osteocyte viability with glucocorticoid treatment: relation to histomorphometry

  2003cited by this paper
• Reduced Iliac Cancellous Osteocyte Density in Patients With Osteoporotic Vertebral Fracture

  2003cited by this paper
• Bone loss associated with gastrointestinal disease: prevalence and pathogenesis

  2003influential reference
• The pathophysiology of bone disease in gastrointestinal disease.

  2003cited by this paper
• Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone.

  2002cited by this paper
• Bone Histomorphometric and Biochemical Marker Results of a 2‐Year Placebo‐Controlled Trial of Raloxifene in Postmenopausal Women

  2002cited by this paper
• Induction of MCP-1 Expression in Airway Epithelial Cells: Role of CCR2 Receptor in Airway Epithelial Injury

  2002cited by this paper
• Inhibition of osteoblast differentiation by tumor necrosis factor-alpha.

  2000influential reference
• Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease

  2000cited by this paper
• Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease

  2000cited by this paper
• Femoral neck osteopenia in patients with inflammatory bowel disease

  1998influential reference
• Increased bone resorption in patients with Crohn’s disease

  1998cited by this paper
• Altered Bone Metabolism in Inflammatory Bowel Disease

  1998cited by this paper
• Monocyte chemoattractant protein-1 induces monocyte recruitment that is associated with an increase in numbers of osteoblasts.

  1997cited by this paper
• Reduced bone density in patients with inflammatory bowel disease.

  1997cited by this paper
• Metabolic bone assessment in patients with inflammatory bowel disease.

  1995cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.

  1995influential reference
• Involvement of interleukin 1 and tumour necrosis factor alpha as endogenous growth factors in human osteoblastic cells.

  1995cited by this paper
• Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease

  1993cited by this paper
• Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.

  1992cited by this paper
• Enhanced mucosal cytokine production in inflammatory bowel disease.

  1992cited by this paper
• Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

  1991cited by this paper
• A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects.

  1990cited by this paper
• Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces

  1989cited by this paper
• Classification of inflammatory bowel disease.

  1989cited by this paper
• Interleukin-1 beta is a potent inhibitor of bone formation in vitro.

  1987cited by this paper
• Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

  1987cited by this paper
• Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease.

  1984cited by this paper
• Human Bone Cells in Culture. A Novel System for the Investigation of Bone Cell Metabolism

  1983cited by this paper
• Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects.

  1982cited by this paper
• Role of cell shape in growth control

  1978influential reference
• The quantitative histochemistry of brain. II. Enzyme measurements.

  1954cited by this paper

• No citing papers are available for this paper.